Moteur de recherche d’entreprises européennes
Financement de l’UE (6 293 855 €) : Devenez fort pour lutter contre le cancer pédiatrique : une intervention par l’exercice pour les enfants et les adolescents qui suivent un traitement anticancéreux Hor11/02/2021 Programme de recherche et d'innovation de l'UE « Horizon »
Texte
Devenez fort pour lutter contre le cancer pédiatrique : une intervention par l’exercice pour les enfants et les adolescents qui suivent un traitement anticancéreux
Cancer is the first leading cause of death by non-communicable diseases in children in Europe. During cancer treatment, patients’ morbidity is increased due to physical inactivity, cancer-related fatigue (CRF) and reduced health-related quality of life (HRQoL). Adapted exercise training in cancer patients, called exercise oncology, is an increasingly recognised, promising health care intervention. In adults, exercise oncology revealed notable effects on tolerance and completion rate of cancer treatment. However, in childhood cancer patients, strong evidence for exercise efficiency is lacking. Thus, precision exercise training is not part of standard care in paediatric oncology and does not reach the majority of patients. By pooling the leading expertise on a European and cross-Atlantic level, the FORTEe project aims to evaluate a personalised and standardised exercise intervention for children and adolescents undergoing anti-cancer treatment. In the randomised, controlled FORTEe trial, high evidence for an innovative, patient-centred exercise treatment will be generated. FORTEe promotes exercise oncology that aims at making patients “stronger to fight childhood cancer”. Supervised exercise training intents to increase muscle strength and reduce muscular atrophy due to bedrest. CRF and HRQoL can be improved and in the future, these benefits may help to fight childhood cancer by increasing therapy efficiency and survival rate. Within the project, digital, innovative technologies such as augmented reality will be developed and applied to make the exercise training more effective, age-adapted and personalised. Moreover, FORTEe will stimulate translational research to provide access to paediatric exercise oncology as a new health care intervention. As a progress beyond the current state-of-the-art, FORTEe has the ambition to implement paediatric exercise oncology as an evidence-based standard in clinical care for all childhood cancer patients across the EU and beyond.
| Centre de Lutte Contre le Cancer Leon Berard | 313 813 € |
| Concentris Research Management GmbH | 569 750 € |
| Deutsche Sporthochschule Koln | 73 500 € |
| Fondazione Irccs Istituto Nazionale DEI Tumori | 278 513 € |
| Fondazione Monza E Brianza Per IL Bambino E LA SUA Mamma Onlus | 698 440 € |
| Forma 3D Poslovne Storitve d.o.o. | 140 375 € |
| Fundatia Youth Cancer Europe | 55 375 € |
| Nurogames GmbH | 347 000 € |
| Oxford Brookes University | 672 991 € |
| Pixformance Sports GmbH | 76 250 € |
| Region Hovedstaden | 390 640 € |
| Universidad Europea de Madrid SA | 296 764 € |
| Universitaetsklinikum Essen | 92 671 € |
| Universitaetsmedizin DER Johannes Gutenberg-Universitaet Mainz | 1 704 398 € |
| Universitatsklinikum Heidelberg | 484 869 € |
| Univerzitetni Klinicni Center Ljubljana | 98 507 € |
https://cordis.europa.eu/project/id/945153
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.